SARS-CoV-2 N gene |
Colorimetric |
RNA/DNA attached gold nanoparticle |
10 minutes |
.18 ng/μL |
16
|
SARS-CoV-2 spike protein |
Colorimetric |
Antibody-conjugated gold nanoparticles |
5 minutes |
1 ng/mL |
23
|
SARS-CoV-2 spike protein |
Colorimetric |
MNAzyme - conjugated gold nanoparticles |
5 minutes |
90% for clinical samples |
39
|
SARS-CoV-2 S, N & P gene |
Colorimetric |
Antibody-conjugated gold nanoparticles |
20 minutes |
95% for clinical samples |
21
|
SARS-CoV-2 IgM/IgG antibodies |
Colorimetric based Lateral Flow |
Nucleoprotein attached gold nanoparticles |
15 minutes |
93% for clinical samples |
27
|
SARS-CoV-2 RNA |
Colorimetric CRISPR/Cas |
RNA/DNA attached gold nanoparticle |
15 minutes |
95.2% for clinical samples |
22
|
SARS-CoV-2 spike protein |
SERS |
Antibody-conjugated gold nanoparticles |
10 minutes |
4 pg/mL |
23
|
SARS-CoV-2 spike protein |
SERS |
Antibody attached graphene |
15 minutes |
3.75 fg/mL |
38
|
SARS-CoV-2 IgM/IgG antibodies |
SERS based LFA |
Antigen attached SiO2@Ag nanoparticle |
20 minutes |
100% for clinical samples |
35
|
SARS-CoV-2 spike protein |
SERS |
Antibody-conjugated gold nanoparticles |
20 minutes |
87.7% clinical sample |
42
|
SARS-CoV-2 spike protein |
NSET |
Aptamer-conjugated gold nanoparticles |
10 minutes |
130 fg/mL |
24
|
SARS-CoV-2 spike protein |
Fluorescence |
ACE2 attached SWCNT |
90 minutes |
12.6 nM |
37
|
SARS-CoV-2 IgG and IgM |
Fluorescence based LFA |
Antigen/SiO2@Au@QD nanobeads |
15 minutes |
100% for clinical samples |
28
|
SARS-CoV-2 spike protein |
NSET |
Antibody coated quantum dots |
20 minutes |
200 fg/mL |
30
|
SARS-CoV-2 spike protein |
Field effect transistor |
Antibody coated MXene-graphene |
50 seconds |
1 fg/mL |
36
|
SARS-CoV-2 RNA |
RT-PCR |
|
6 hours |
97% for clinical samples |
8
|
SARS-CoV-2 RNA |
CRISPR-Cas |
|
40 minutes |
95% for clinical samples |
11
|
SARS-CoV-2 antigen |
LFA |
|
15 minutes |
95% for clinical samples |
8
|